NEW YORK--(BUSINESS WIRE)-- IFF (NYSE: IFF) today announced that it has entered into a definitive agreement to sell its Pharma Solutions business unit to French leader of plant-based ingredients ...

Improving the World of Dietary Supplements with a Breadth of Proven Brands. "We are excited to highlight vivid examples of how our high-quality functional ingredients and technical expertise help our ...

Global Leading Excipient Supplier to Highlight Innovations in Oral Disintegrating Tablets, Controlled Release Formulations, and Low-Nitrite Solutions TOKYO--(BUSINESS WIRE)-- IFF (NYSE:IFF) Pharma ...

Low Nitrite METHOCEL™ HPMC reduces the potential for nitrosamine formation and provides consistent results in finished dosages. NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions, a global ...

NEW YORK, Dec. 12, 2024 /PRNewswire/ -- IFF (NYSE:IFF) Pharma Solutions announces the launch of its new customer experience platform, AnswerCenter. This customized environment is designed to provide ...

Roquette has agreed to acquire IFF Pharma Solutions, a producer of ingredients for oral dosage solutions, for an enterprise value of up to $2.85 billion. IFF is a leading producer of excipients for ...

Goldman Sachs analyst Adam Samuelson has maintained their neutral stance on IFF stock, giving a Hold rating on March 8. Adam Samuelson has given his Hold rating due to a combination of factors ...

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) Pharma Solutions is excited to announce its participation at Vitafoods™ Europe 2025, the premier global nutraceutical event. The team will showcase its ...

IFF (NYSE:IFF) Pharma Solutions will showcase its cutting-edge excipient technologies at CPHI Japan 2025. The IFF Pharma Solutions team will highlight its innovations in oral disintegrating tablets ...